Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 69-74-9
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
69-74-9 |
Appearance:: |
White Powder |
Molecular Formula:: |
C9H14ClN3O5 |
Molecular Weight:: |
279.67800 |
EINECS NO:: |
200-713-9 |
MDL NO:: |
MFCD00012839 |
CAS NO:: |
69-74-9 |
Appearance:: |
White Powder |
Molecular Formula:: |
C9H14ClN3O5 |
Molecular Weight:: |
279.67800 |
EINECS NO:: |
200-713-9 |
MDL NO:: |
MFCD00012839 |
Product Description:
Product Name: Cytarabine hydrochloride CAS NO: 69-74-9
Synonyms:
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2-pyrimidinone;
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one;
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;
Chemical & Physical Properties:
Appearance: White powder
Assay :≥99.0%
Boiling Point: 545.7℃ at 760 mmHg
Melting Point: 180-182℃
Flash Point: 283.8℃
Stability: Stable. Combustible. Incompatible with strong oxidizing agents.
Storage Condition: 2-8℃
Safety Information:
Symbols: GHS07, GHS08
Signal Word: Warning
Safety Statements: S26-S36/37
HS Code: 2942000000
WGK Germany: 3
RTECS: HA5500000
Risk Statements: R36; R43; R63
Hazard Code: Xn
Hazard Declaration: H317; H319; H341; H361
Caution Statements: P280; P305 + P351 + P338
Antitumor drugs. The main treatment of acute leukemia and gastrointestinal cancer, the majority of solid tumors ineffective. Conjunctivitis of herpes zoster, herpes simplex sex also has certain curative effect. Bone marrow suppression and digestive tract reactions are common, and a few patients may have abnormal liver function, fever, and rash. Blood images should be strictly checked during medication. Anti - malignant tumor drugs, acute myelogenous leukemia is the drug of choice. For acute leukemia, also for head and neck squamous cell cancer, external for viral keratitis and epidemic conjunctivitis, etc.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.